Exelixis | Capital Ordinário



Ordinary Share Capital Alterar Data
Acadia Pharmaceuticals USD 16K 0 2024-12
Agios Pharmaceuticals USD 73K 0 2024-12
Amgen USD 33.53B 140M 2024-12
AstraZeneca USD 388M 0 2024-12
Bayer EUR 2.52B 0 2024-12
BioMarin Pharmaceutical USD 191K 0 2024-12
Bristol-Myers Squibb USD 292M 0 2024-12
Cytokinetics USD 118K 0 2024-12
Eisai JPY 44.99B 0 2024-12
Eli Lilly USD 592.4M 1.5M 2024-12
Exelixis USD 282K 4K 2025-01
Genmab DKK 66M 0 2024-12
Glaxosmithkline GBP 1.35B 0 2024-12
Incyte USD 193K 1000 2024-12
Ionis Pharmaceuticals USD 158K 0 2024-12
MacroGenics USD 628K 1000 2024-12
Merck USD 1.79B 0 2024-12
Moderna USD 38.6K 100 2024-12
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 480M 0 2024-12
Takeda JPY 1.69T 0 2024-12
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Xencor USD 703K 2K 2024-12



Exelixis Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.